Department of Pathology, Children's Hospital Boston and Harvard Medical School, Boston, MA 02115, USA.
Semin Pediatr Neurol. 2009 Dec;16(4):179-90. doi: 10.1016/j.spen.2009.09.003.
A major challenge in understanding brain injury in the premature brain is the establishment of the precise human neuropathology at the cellular and molecular levels, as such knowledge is the foundation upon which the elucidation of the cause(s), scientific experimentation, and therapies in the field is by necessity based. In this essay, I provide my perspective as a pediatric neuropathologist upon pathologic studies in the developing human brain itself, including a review of past, present, and future aspects. My focus is upon the path that has brought us to the current recognition that preterm brain injury is a complex of white and gray matter damage that results in the modification of key developmental pathways during a critical period, which in turn defines the adverse clinical outcomes as important as the primary insult itself. The evolution of this recognition, as well as the introduction of the term "encephalopathy of prematurity" for the complex of gray and white matter damage because of acquired and developmental mechanisms, is discussed. Our enhanced understanding of the fundamental neuropathology of the human preterm brain should bring us closer to more effective therapy as the need to prevent and treat injury to developing oligodendrocytes and neurons in combination is appreciated.
理解早产儿脑损伤的一个主要挑战是在细胞和分子水平上建立精确的人类神经病理学,因为这种知识是阐明该领域病因、科学实验和治疗方法的基础。在本文中,我作为一名儿科神经病理学家,提供了我对发育中人类大脑自身病理研究的看法,包括对过去、现在和未来方面的回顾。我的重点是探讨使我们认识到早产儿脑损伤是一种白质和灰质损伤的复杂疾病,这种损伤会导致关键发育途径在关键时期发生改变,进而定义不良的临床结局与原发性损伤本身同样重要。讨论了这种认识的演变,以及由于获得性和发育性机制导致的灰白质损伤的“早产儿脑病”这一术语的引入。我们对人类早产儿脑基本神经病理学的认识的提高,应该使我们更接近更有效的治疗方法,因为人们认识到需要预防和治疗发育中的少突胶质细胞和神经元的损伤。